Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva-Maria Gamper

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Patient-Reported Outcomes|February 21, 2019
Correction to: do patients consider computer-adaptive measures more appropriate than static questionnaires?Eva-Maria Gamper, Caroline Martini, Morten Aagaard Petersen, et al.
Breast Cancer Research and Treatment|August 31, 2016
Cost-utility analyses of drug therapies in breast cancer: a systematic reviewVirginie Nerich, Sopany Saing, Eva Maria Gamper, et al.
Journal of Patient-Reported Outcomes|January 30, 2019
Do patients consider computer-adaptive measures more appropriate than static questionnaires?Eva-Maria Gamper, Caroline Martini, Morten Aagaard Petersen, et al.
Breast Cancer Research and Treatment|May 13, 2017
Critical appraisal of health-state utility values used in breast cancer-related cost-utility analysesVirginie Nerich, Sopany Saing, Eva-Maria Gamper, et al.
Applied Health Economics and Health Policy|June 16, 2020
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30Virginie Nerich, Eva Maria Gamper, Richard Norman, et al.
Breast Care (Basel, Switzerland)|September 18, 2010
Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical ImplicationJohannes Giesinger, Georg Kemmler, Verena Meraner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health StatesEva-Maria Gamper, Bernhard Holzner, Madeleine T King, et al.
Journal of Patient-Reported Outcomes|May 4, 2022
The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weightsEva-Maria Gamper, Madeleine T King, Richard Norman, et al.
Health and Quality of Life Outcomes|September 12, 2016
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumoursCaroline Martini, Eva-Maria Gamper, Lisa Wintner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical RoutineCaroline Martini, Sabine Buxbaum, Margarida Rodrigues, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Patient-Reported Outcomes|February 21, 2019
Correction to: do patients consider computer-adaptive measures more appropriate than static questionnaires?Eva-Maria Gamper, Caroline Martini, Morten Aagaard Petersen, et al.
Breast Cancer Research and Treatment|August 31, 2016
Cost-utility analyses of drug therapies in breast cancer: a systematic reviewVirginie Nerich, Sopany Saing, Eva Maria Gamper, et al.
Journal of Patient-Reported Outcomes|January 30, 2019
Do patients consider computer-adaptive measures more appropriate than static questionnaires?Eva-Maria Gamper, Caroline Martini, Morten Aagaard Petersen, et al.
Breast Cancer Research and Treatment|May 13, 2017
Critical appraisal of health-state utility values used in breast cancer-related cost-utility analysesVirginie Nerich, Sopany Saing, Eva-Maria Gamper, et al.
Applied Health Economics and Health Policy|June 16, 2020
French Value-Set of the QLU-C10D, a Cancer-Specific Utility Measure Derived from the QLQ-C30Virginie Nerich, Eva Maria Gamper, Richard Norman, et al.
Breast Care (Basel, Switzerland)|September 18, 2010
Towards the Implementation of Quality of Life Monitoring in Daily Clinical Routine: Methodological Issues and Clinical ImplicationJohannes Giesinger, Georg Kemmler, Verena Meraner, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 13, 2018
Test-Retest Reliability of Discrete Choice Experiment for Valuations of QLU-C10D Health StatesEva-Maria Gamper, Bernhard Holzner, Madeleine T King, et al.
Journal of Patient-Reported Outcomes|May 4, 2022
The EORTC QLU-C10D discrete choice experiment for cancer patients: a first step towards patient utility weightsEva-Maria Gamper, Madeleine T King, Richard Norman, et al.
Health and Quality of Life Outcomes|September 12, 2016
Systematic review reveals lack of quality in reporting health-related quality of life in patients with gastroenteropancreatic neuroendocrine tumoursCaroline Martini, Eva-Maria Gamper, Lisa Wintner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 26, 2018
Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical RoutineCaroline Martini, Sabine Buxbaum, Margarida Rodrigues, et al.
Pageof 4